Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
COG-ANBL-1232
NCT02176967
 Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase III |
Martine Therrien
514-345-4931 poste 3396
|
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
COG-AGCT1531
NCT03067181
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase III |
Martine Therrien
514-345-4931 poste 3396
|
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
COG-AALL1631
NCT03007147
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase III |
Clemence Noury
514-345-4931 poste 6848
|
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
LCH-IV
NCT02205762
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase II |
Maud Frizot
514-345-4931 poste 5467
|
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
SJMB12
NCT01878617
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase II |
Linda Hershon
514-345-4931 poste 5899
|
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
NMTRC014
NCT02679144
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase II |
Martine Therrien
514-345-4931 poste 3396
|
A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia
COG-AALL1521
NCT02723994
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase II |
Clemence Noury
514-345-4931 poste 6848
|
A Phase 1/2 Study of the Oral TRK Inhibitor LOXO-101 (Larotrectinib) in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors
LOXO-TRK-15003
NCT02637687
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase I-II |
Annie La Haye
514 345-4931 poste 6325
|
Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
CFZ008
NCT02303821
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase I-II |
Lynda Dufresne
514-345-4931 poste 4969
|
A Phase I and Enrichment Study of Low-dose Metronomic Topotecan and Pazopanib in Pediatric Patients With Recurrent or Refractory Solid Tumours Including CNS Tumours
IND.217 (TOPAZ)
NCT02303028
Recruiting
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Phase I |
Linda Hershon
514-345-4931 poste 5899
|
Groupe d'étude en oncologie du Québec